Clinical Trials in Phoenix

Showing 4821-4840 of 12,606 trials

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

NCT04025216

Multi-center, open-label, first in human Phase 1 study of the safety, tolerability, feasibility, and preliminary efficacy of the administration of genetically modified autologous T cells (CART-TnMUC1 cells) engineered to express a chimeric antigen receptor (CAR) capable of recognizing the tumor antigen, TnMUC1 and activating the T cell (CART- TnMUC1 cells).

Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more

Kite, A Gilead Company16 participantsStarted Oct 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Tampa, Florida, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

NCT02116972

The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control).

Osteoarthritis of the Knee

Pacira Pharmaceuticals, Inc310 participantsStarted Apr 2014

Anniston, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +41 more locations

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Find Trials by Condition in Phoenix

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)

A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Prospective Clinicogenomic Program

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

EPI-743 for Mitochondrial Respiratory Chain Diseases

Study of Probable Benefit of the Neuro-Spinal Scaffold™ in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Tracking Renal Tumors After Cryoablation Evaluation

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma